RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,727,582 | -37.6% | 205,420 | -6.8% | 0.00% | -25.0% |
| Q2 2023 | $2,769,254 | -37.3% | 220,482 | -17.8% | 0.00% | -42.9% |
| Q1 2023 | $4,415,739 | +24.1% | 268,108 | +12.5% | 0.01% | +16.7% |
| Q4 2022 | $3,559,335 | +7.8% | 238,242 | +61.4% | 0.01% | +20.0% |
| Q3 2022 | $3,303,000 | +15.0% | 147,636 | -13.7% | 0.01% | +25.0% |
| Q2 2022 | $2,873,000 | +10.7% | 171,136 | +102.2% | 0.00% | +33.3% |
| Q1 2022 | $2,595,000 | – | 84,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |